PacBio’s Revio long-read sequencing system to help Bioscientia solve complex genetic cases

FHS
July 10, 2023
6:53 am

PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced that Bioscientia is using its Revio long-read sequencing system to expand its genomics research projects and sequence several thousand human genomes per year.

Lung cancer biomarker campaign, launched with AstraZeneca, boosts its reach and adds pharma supporters

The groups are called the MET Crusaders, the EGFR Resistors, the KRAS Kickers and the ROS1ders — and members are non small cell lung cancer

September 6, 2023

China NMPA approves Dizal’s golidocitinib for PTCL treatment

PTCL represents a diverse group of aggressive non-Hodgkin lymphomas, with patients at a high risk of disease relapse. Credit: Nemes Laszlo / Shutterstock. The National

June 20, 2024

The ADC hot streak continues: J&J to buy cancer drug developer Ambrx Biopharma

Johnson & Johnson said Monday that it would purchase Ambrx Biopharma for nearly $2 billion, picking up a company specializing in targeted chemotherapy treatments —

January 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.